Richard A. Moffitt

ORCID: 0000-0003-2723-5902
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Cancer Cells and Metastasis
  • Machine Learning in Healthcare
  • Epigenetics and DNA Methylation
  • Diabetes and associated disorders
  • COVID-19 and healthcare impacts
  • Glioma Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • AI in cancer detection
  • Intensive Care Unit Cognitive Disorders
  • Single-cell and spatial transcriptomics
  • Renal cell carcinoma treatment
  • Cancer, Hypoxia, and Metabolism
  • Neuroendocrine Tumor Research Advances
  • Infectious Encephalopathies and Encephalitis
  • Pancreatitis Pathology and Treatment
  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • SARS-CoV-2 and COVID-19 Research
  • Cell Image Analysis Techniques
  • Respiratory viral infections research
  • Pancreatic function and diabetes

Emory University
2007-2025

Stony Brook University
2017-2024

Collaborative Research Group
2024

Cohort (United Kingdom)
2024

Stony Brook Medicine
2018-2024

Johns Hopkins University
2014-2023

Stony Brook School
2019-2021

State University of New York
2018-2021

UNC Lineberger Comprehensive Cancer Center
2014-2020

Segeberger Kliniken
2020

Benjamin J. Raphael Ralph H. Hruban Andrew J. Aguirre Richard A. Moffitt Jen Jen Yeh and 95 more Chip Stewart A. Gordon Robertson Andrew D. Cherniack Manaswi Gupta Gad Getz Stacey Gabriel Matthew Meyerson Carrie Cibulskis Suzanne S. Fei Toshinori Hinoue Hui Shen Peter W. Laird Shiyun Ling Yiling Lu Gordon B. Mills Rehan Akbani Phillipe Loher Eric Londin Isidore Rigoutsos Aristeidis G. Telonis Ewan A. Gibb Anna Goldenberg Aziz M. Mezlini Katherine A. Hoadley Eric A. Collisson Eric S. Lander Bradley A. Murray Julian M. Hess Mara Rosenberg Louis Bergelson Hailei Zhang Juok Cho Grace Tiao Jaegil Kim Dimitri Livitz Ignaty Leshchiner Brendan Reardon Eliezer M. Van Allen Atanas Kamburov Rameen Beroukhim Gordon Saksena Steven E. Schumacher Michael S. Noble David I. Heiman Nils Gehlenborg Jaegil Kim Michael S. Lawrence Volkan Adsay Gloria M. Petersen David S. Klimstra Nabeel Bardeesy Mark D.M. Leiserson Reanne Bowlby L. Sylvia İnanç Birol Karen Mungall Sara Sadeghi John N. Weinstein Paul T. Spellman Yuexin Liu Laufey T. Ámundadóttir Joel E. Tepper Aatur D. Singhi Rajiv Dhir Paul Drwiega Thomas C. Smyrk Lizhi Zhang Paula Kim Jay Bowen Jessica Frick Julie M. Gastier‐Foster Mark Gerken Kevin Lau Kristen Leraas Tara M. Lichtenberg Nilsa C. Ramirez Jeremy Renkel Mark E. Sherman Lisa Wise Peggy Yena Erik Zmuda Juliann Shih Adrian Ally Miruna Balasundaram Rebecca Carlsen Andy Chu Eric Chuah Amanda Clarke Noreen Dhalla Robert A. Holt Steven J.M. Jones Darlene Lee Yussanne Ma Marco A. Marra Michael Mayo

10.1016/j.ccell.2017.07.007 article EN cc-by-nc-nd Cancer Cell 2017-08-01

Pancreatic cancer is the most lethal common solid malignancy. Systemic therapies are often ineffective, and predictive biomarkers to guide treatment urgently needed. We generated a pancreatic patient-derived organoid (PDO) library that recapitulates mutational spectrum transcriptional subtypes of primary cancer. New driver oncogenes were nominated transcriptomic analyses revealed unique clusters. PDOs exhibited heterogeneous responses standard-of-care chemotherapeutics investigational...

10.1158/2159-8290.cd-18-0349 article EN Cancer Discovery 2018-05-31
Siyuan Zheng Andrew D. Cherniack Ninad Dewal Richard A. Moffitt Ludmila Danilova and 95 more Bradley A. Murray Antônio Marcondes Lerário Tobias Else Theo Knijnenburg Giovanni Ciriello Seungchan Kim Guillaume Assié Olena Morozova Rehan Akbani Juliann Shih Katherine A. Hoadley Toni K. Choueiri Jens Waldmann Özgür Mete A. Gordon Robertson Hsin-Ta Wu Benjamin J. Raphael Lina Shao Matthew Meyerson Michael J. Demeure Felix Beuschlein Anthony J. Gill Stan B. Sidhu Madson Q. Almeida Maria Candida Barisson Villares Fragoso Leslie Cope Electron Kebebew Mouhammed Amir Habra Timothy G. Whitsett Kimberly J. Bussey William E. Rainey L. Sylvia Jérôme Bertherat Martin Faßnacht David A. Wheeler Gary D. Hammer Thomas J. Giordano Roel G.W. Verhaak Siyuan Zheng Roel G.W. Verhaak Thomas J. Giordano Gary D. Hammer Andrew D. Cherniack Ninad Dewal Richard A. Moffitt Ludmila Danilova Bradley A. Murray Antônio Marcondes Lerário Tobias Else Theo Knijnenburg Giovanni Ciriello Seungchan Kim Guillaume Assié Olena Morozova Rehan Akbani Juliann Shih Katherine A. Hoadley Toni K. Choueiri Jens Waldmann Özgür Mete A. Gordon Robertson Hsin-Tu Wu Benjamin J. Raphael Matthew Meyerson Michael J. Demeure Felix Beuschlein Anthony J. Gill Stan B. Sidhu Madson Q. Almeida Maria Candida Barisson Villares Fragoso Leslie Cope Electron Kebebew Mouhammed Amir Habra Timothy G. Whitsett Kimberly J. Bussey William E. Rainey L. Sylvia Jérôme Bertherat Martin Faßnacht David A. Wheeler Christopher C. Benz Adrian Ally Miruna Balasundaram Reanne Bowlby Denise Brooks Yaron S.N. Butterfield Rebecca Carlsen Noreen Dhalla Ranabir Guin Robert A. Holt Steven J.M. Jones L. Sylvia Darlene Lee Haiyan I. Li Lynette Lim

10.1016/j.ccell.2016.04.002 article EN publisher-specific-oa Cancer Cell 2016-05-01

Purpose: To perform real-time whole genome sequencing (WGS) and RNA (RNASeq) of advanced pancreatic ductal adenocarcinoma (PDAC) to identify predictive mutational transcriptional features for better treatment selection.Experimental Design: Patients with PDAC were prospectively recruited prior first-line combination chemotherapy. Fresh tumor tissue was acquired by image-guided percutaneous core biopsy WGS RNASeq. Laser capture microdissection performed all cases. Primary endpoint feasibility...

10.1158/1078-0432.ccr-17-2994 article EN Clinical Cancer Research 2017-12-29

Clinically relevant subtypes exist for pancreatic ductal adenocarcinoma (PDAC), but molecular characterization is not yet standard in clinical care. We implemented a biopsy protocol to perform time-sensitive whole-exome sequencing and RNA patients with advanced PDAC. Therapeutically genomic alterations were identified 48% (34/71) pathogenic/likely pathogenic germline 18% (13/71) of patients. Overall, 30% (21/71) enrolled experienced change management as result data. Twenty-six had and/or...

10.1158/2159-8290.cd-18-0275 article EN Cancer Discovery 2018-06-14
Tellen D. Bennett Richard A. Moffitt Janos Hajagos Benjamin Amor Adit Anand and 95 more Mark M. Bissell Katie R. Bradwell Carolyn Bremer James Brian Byrd Alina Denham Peter E. DeWitt Davera Gabriel Brian T. Garibaldi Andrew T. Girvin Justin Guinney Elaine Hill Stephanie Hong Hunter Jimenez Ramakanth Kavuluru Kristin Kostka Harold P. Lehmann Eli B. Levitt Sandeep K. Mallipattu Amin Manna Julie A. McMurry Michele Morris John Muschelli Andrew J. Neumann Matvey B. Palchuk Emily Pfaff Zhenglong Qian Nabeel Qureshi Seth Russell Heidi Spratt Anita Walden Andrew E. Williams Jacob T. Wooldridge Yun Jae Yoo Xiaohan Tanner Zhang Richard L. Zhu Christopher P. Austin Joel Saltz Kenneth Gersing Melissa Haendel Christopher G. Chute Joel Gagnier Siqing Hu Kanchan Lota Sarah E. Maidlow David A. Hanauer Kevin J. Weatherwax Nikhila Gandrakota Rishikesan Kamaleswaran Greg S. Martin Jingjing Qian Jason E. Farley Patricia A. Francis Dazhi Jiao Hadi Kharrazi Justin Reese Mariam Deacy Usman Ullah Sheikh Jake Y. Chen Michael Quinn Patton T. Bennett Ramsey Jasvinder A. Singh James J. Cimino Jing Su William G. Adams Timothy Q. Duong John B. Buse Jessica Y. Islam Jihad S. Obeid Stéphane M. Meystre Steve Patterson Misha Zemmel Ron Grider A. Pérez Martínez Carlos Antônio do Nascimento Santos Julian Solway Ryan G. Chiu Gerald B. Brown Jia-Feng Cui Sharon X. Liang Kamil Khanipov Jeremy Richard Harper Peter J. Embí David Eichmann Boyd M. Knosp William B. Hillegass Chunlei Wu James R. Aaron Darren W. Henderson Muhammad Gul Tamela Harper Daniel R. Harris Jeffery Talbert Neil Bahroos Steven M. Dubinett Jomol Mathew

The National COVID Cohort Collaborative (N3C) is a centralized, harmonized, high-granularity electronic health record repository that the largest, most representative COVID-19 cohort to date. This multicenter data set can support robust evidence-based development of predictive and diagnostic tools inform clinical care policy.

10.1001/jamanetworkopen.2021.16901 article EN cc-by-nc-nd JAMA Network Open 2021-07-13

Post-acute sequelae of SARS-CoV-2 infection, known as long COVID, have severely affected recovery from the COVID-19 pandemic for patients and society alike. Long COVID is characterised by evolving, heterogeneous symptoms, making it challenging to derive an unambiguous definition. Studies electronic health records are a crucial element US National Institutes Health's RECOVER Initiative, which addressing urgent need understand identify treatments, accurately who has it-the latter aim this study.

10.1016/s2589-7500(22)00048-6 article EN cc-by-nc-nd The Lancet Digital Health 2022-05-16

Abstract Purpose: Molecular subtyping for pancreatic cancer has made substantial progress in recent years, facilitating the optimization of existing therapeutic approaches to improve clinical outcomes cancer. With advances treatment combinations and choices, it is becoming increasingly important determine ways place patients on best therapies upfront. Although various molecular systems have been proposed, consensus regarding proposed subtypes, as well their relative utility, remains largely...

10.1158/1078-0432.ccr-19-1467 article EN Clinical Cancer Research 2019-11-21

// Marybeth Anderson 1, 2 , Raoud Marayati Richard Moffitt and Jen Yeh 2, 3 1 Curriculum in Genetics & Molecular Biology, The University of North Carolina, Chapel Hill, NC Lineberger Comprehensive Cancer Center, Departments Surgery Pharmacology, Correspondence to: Yeh, email: jjyeh@med.unc.edu Keywords: pancreatic cancer, hexokinase glycolysis, metastasis Received: January 19, 2016     Accepted: May 02, Published: June 01, 2016 ABSTRACT Pancreatic ductal...

10.18632/oncotarget.9760 article EN Oncotarget 2016-06-01

<h3>Importance</h3> Understanding of SARS-CoV-2 infection in US children has been limited by the lack large, multicenter studies with granular data. <h3>Objective</h3> To examine characteristics, changes over time, outcomes, and severity risk factors within National COVID Cohort Collaborative (N3C). <h3>Design, Setting, Participants</h3> A prospective cohort study encounters end dates before September 24, 2021, was conducted at 56 N3C facilities throughout US. Participants included younger...

10.1001/jamanetworkopen.2021.43151 article EN cc-by-nc-nd JAMA Network Open 2022-02-08

Since late 2019, the novel coronavirus SARS-CoV-2 has introduced a wide array of health challenges globally. In addition to complex acute presentation that can affect multiple organ systems, increasing evidence points long-term sequelae being common and impactful. The worldwide scientific community is forging ahead characterize range outcomes associated with infection; however underlying assumptions in these studies have varied so widely resulting data are difficult compareFormal definitions...

10.1101/2021.03.20.21253896 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2021-03-26

Abstract Background Naming a newly discovered disease is difficult process; in the context of COVID-19 pandemic and existence post-acute sequelae SARS-CoV-2 infection (PASC), which includes long COVID, it has proven especially challenging. Disease definitions assignment diagnosis code are often asynchronous iterative. The clinical definition our understanding underlying mechanisms COVID still flux, deployment an ICD-10-CM for USA took nearly 2 years after patients had begun to describe their...

10.1186/s12916-023-02737-6 article EN cc-by BMC Medicine 2023-02-16

Abstract Long COVID, or complications arising from COVID-19 weeks after infection, has become a central concern for public health experts. The United States National Institutes of Health founded the RECOVER initiative to better understand long COVID. We used electronic records available through COVID Cohort Collaborative characterize association between SARS-CoV-2 vaccination and diagnosis. Among patients with infection August 1, 2021 January 31, 2022, we defined two cohorts using distinct...

10.1038/s41467-023-38388-7 article EN cc-by Nature Communications 2023-05-22

Quantitative assessment of spatial relations between tumor and tumor-infiltrating lymphocytes (TIL) is increasingly important in both basic science clinical aspects breast cancer research. We have developed evaluated convolutional neural network analysis pipelines to generate combined maps regions TILs routine diagnostic whole slide tissue images. The provide insight about the structural patterns distribution lymphocytic infiltrates facilitate improved quantification TILs. Both TIL analyses...

10.1016/j.ajpath.2020.03.012 article EN cc-by-nc-nd American Journal Of Pathology 2020-04-08

Abstract Objective In response to COVID-19, the informatics community united aggregate as much clinical data possible characterize this new disease and reduce its impact through collaborative analytics. The National COVID Cohort Collaborative (N3C) is now largest publicly available HIPAA limited dataset in US history with over 6.4 million patients a testament partnership of 100 organizations. Materials Methods We developed pipeline for ingesting, harmonizing, centralizing from 56...

10.1093/jamia/ocab217 article EN cc-by-nc Journal of the American Medical Informatics Association 2021-09-23

The majority of U.S. reports COVID-19 clinical characteristics, disease course, and treatments are from single health systems or focused on one domain. Here we report the creation National COVID Cohort Collaborative (N3C), a centralized, harmonized, high-granularity electronic record repository that is largest, most representative cohort cases controls to date. This multi-center dataset supports robust evidence-based development predictive diagnostic tools informs critical care policy.In...

10.1101/2021.01.12.21249511 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2021-01-13

Prior observational studies suggest that aspirin use may be associated with reduced mortality in high-risk hospitalized patients COVID-19, but aspirin's efficacy moderate COVID-19 is not well studied.To assess whether early lower odds of in-hospital COVID-19.Observational cohort study 112 269 enrolled from January 1, 2020, through September 10, 2021, at 64 health systems the United States participating National Institute Health's COVID Cohort Collaborative (N3C).Aspirin within first day...

10.1001/jamanetworkopen.2022.3890 article EN cc-by-nc-nd JAMA Network Open 2022-03-24

This cohort study uses data from the US National COVID Cohort Collaborative to evaluate upper airway infections in children during surge of Omicron (B.1.1.529) variant SARS-CoV-2 US.

10.1001/jamapediatrics.2022.1110 article EN cc-by JAMA Pediatrics 2022-04-15

Abstract Bulk analyses of pancreatic ductal adenocarcinoma (PDAC) samples are complicated by the tumor microenvironment (TME), i.e. signals from fibroblasts, endocrine, exocrine, and immune cells. Despite this, we others have established stroma subtypes with prognostic significance. However, understanding underlying driving distinct stromal landscapes is still incomplete. Here integrate 92 single cell RNA-seq seven independent studies to build a reproducible PDAC atlas focus on tumor-TME...

10.1038/s41467-023-40895-6 article EN cc-by Nature Communications 2023-08-26
Coming Soon ...